MedTrace Logo

Combination Antimalarials in Uncomplicated Malaria

NCT00203801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2018-10-19

No results posted yet for this study

Summary

The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine.

Conditions

Interventions

DRUG

Sulfadoxine-pyrimethamine

DRUG

Artesunate plus sulfadoxine-pyrimethamine

DRUG

Artemether-lumefantrine

Sponsors & Collaborators

Principal Investigators

  • Karen Barnes, MBChB · University of Cape Town

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2005-07-31
Completion
2005-07-31

Countries

  • Eswatini
  • Mozambique
  • South Africa

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203801 on ClinicalTrials.gov